BRIEF-Vertex Pharmaceuticals says cystic fibrosis combo succeeds in late stage trials

June 24 Tue Jun 24, 2014 7:12am EDT

June 24 (Reuters) - Vertex Pharmaceuticals -

* Vertex Pharmaceuticals says cystic fibrosis combo of kalydeco and lumacaftor succeeds in late stage trials

* Vertex Pharmaceuticals says combo improved lung function in patients with most common genetic mutation associated with rare lung disease

* Vertex Pharmaceuticals says would file applications for U.S. And european approval for the combo in Q4 Source text for Eikon: Further company coverage: